Home Stock Market The US provides India with emergency components of vaccines and medical supplies

The US provides India with emergency components of vaccines and medical supplies


© Reuters. A person with free oxygen-assisted breathing problems in her car at Gurudwara, in Ghaziabad


By Andrea Shalal

WILMINGTON (Reuters) – The United States will immediately supply raw materials for COVID-19 vaccine, medical equipment, and protective gear to help India cope with the massive surge in COVID-19 infection, a A White House spokesman said on Sunday.

National Security Council spokesman Emily Horne said in a statement: “The United States is working around the clock to deploy available resources and supplies.”

Horne said these materials will help India produce the Covishield vaccine. The United States will also submit treatments, rapid diagnostic test kits, and ventilators.

Washington is under increasing pressure to help India, the world’s largest democracy, after Britain, France and Germany pledged aid over the weekend.

Indian Prime Minister Narendra Modi urges all citizens to be vaccinated and to be cautious as the country sets a global record for the number of COVID-19 infections in just one day. (Illustrative image of global case and number of deaths) https://tmsnrt.rs/34pvUyi

The United States is also pursuing options to supply India with oxygen production and related supplies.

US officials are also considering sending India their unused doses of COVID-19 vaccine from AstraZeneca (NASDAQ 🙂 Plc, America’s leading Infectious Diseases official, Dr. Anthony Fauci told ABC. News on Sunday. “That is sure to be viewed positively,” Fauci said in an interview.

AstraZeneca’s vaccine is yet to be approved in the United States, which has millions of doses, and top US health officials say they have a sufficient dose of versions approved by three other drug manufacturers. for injection to all Americans in the coming weeks. The nation’s top business lobby group has also pushed authorities to send bottles of AstraZeneca to countries with increasing cases.

The White House did not comment on the possibility of sending the AstraZeneca vaccine to India.

Senior US officials have expressed concern that new variants of the virus emerging in India could undermine progress made in the United States.

The boom also threatens the economic recovery of India, the sixth largest economy in the world.

Horne said the United States will also send a team of experts from the Centers for Disease Control and Prevention (CDC) and the US Agency for International Development to work with India.

In addition to the immediate grant, the US Development Finance Corporation (DFC) will provide funding to significantly expand production capabilities for the Indian vaccine maker Biological E Ltd, or BioE, to enable the company to produce at least 1 billion doses of COVID-19 vaccine by the end of 2022.

Disclaimer: Fusion Media wants to remind you that the data contained in this website is not necessarily real-time nor is it accurate. All CFDs (stocks, indices, futures) and forex prices are not offered by exchanges but by market makers, so the prices may be inaccurate and may differ from actual market price, which means that price is indicative only and not suitable for trading purposes. Consequently, Fusion Media accepts no liability whatsoever for any transaction losses you may incur as a result of using this data.

Fusion Media or anyone associated with Fusion Media will not be liable in any way for loss or damage resulting from dependence on information including data, quotes, charts and buy / sell signals contained in the this site. Please be fully informed about the risks and costs associated with trading the financial markets, which is one of the riskiest investments possible.



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments